Confirmed speakers and schedule to date—
Monday, May 21
1:10–1:50 p.m.
- Amanda Starc, Northwestern University
Promotion and prices: Evidence from new ads for old drugs
1:50–2:30 p.m.
- David Ridley, Duke University
Does Medicare reimbursement drive up drug launch prices?
2:45–3:25 p.m.
- Jennifer Kao, Harvard University
Regulatory incentives for pharmaceutical innovation: The FDA's breakthrough therapy designation
3:25–4:05 p.m.
- Rena Conti, University of Chicago
Entry, exit, and reentry in mature US generic product markets, 2004–2016
4:05–4:45 p.m.
- Joseph DiMasi, Tufts University
- Henry Grabowski, Duke University
Rates of return for new cancer drug development
Tuesday, May 22
9:30–10:10 a.m.
- Ashley Swanson, University of Pennsylvania
Mergers and hospital costs: New evidence from hospital input markets
10:10–10:50 a.m.
- Ginger Zhe Jin, University of Maryland
The unintended consequences of Medicare payment to skilled nursing facilities
11:05–11:45 a.m.
- Ariel Dora Stern, Harvard University
ACA-era Medicaid expansions and pharmaceutical innovation
11:45 a.m.–12:25 p.m.
- Fiona Scott Morton, Yale University
Surprise! Out-of-network billing for emergency care in the United States
1:30–2:10 p.m.
- David Howard, Emory University
The use of False Claims Act lawsuits to reduce low value care
2:10–2:50 p.m.
- Gautam Gowrisankaran, University of Arizona
Reclassification risk in the small group health insurance market
2:50–3:30 p.m.
- Maria Polyakova, Stanford University
Subsidy tagging in privately provided health insurance markets
For more information, please contact Lucinda Lanier.